Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SELLMER KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   3.1% 2.7% 9.2% 7.1% 6.6% 4.4% 17.8% 12.7%   Credit score (0-100)   58 62 27 33 36 46 8 18   Credit rating   BBB BBB BB BBB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,106 2,937 1,838 4,184 6,532 9,909 0.0 0.0   EBITDA   242 468 -162 -708 -572 803 0.0 0.0   EBIT   174 404 -221 -842 -1,151 276 0.0 0.0   Pre-tax profit (PTP)   165.7 389.1 -233.3 -857.3 -1,325.2 -37.0 0.0 0.0   Net earnings   201.8 241.3 -167.3 -585.5 -1,034.7 -532.7 0.0 0.0   Pre-tax profit without non-rec. items   166 389 -233 -857 -1,325 -37.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   161 96.4 602 1,813 3,679 3,325 0.0 0.0   Shareholders equity total   407 540 373 -213 -1,247 -1,780 -1,905 -1,905   Interest-bearing liabilities   0.0 0.0 0.0 3,265 6,782 7,223 1,976 1,976   Balance sheet total (assets)   636 1,098 1,055 3,875 6,392 7,522 71.3 71.3   Net Debt   -264 -401 -75.7 3,068 6,598 6,476 1,976 1,976     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,106 2,937 1,838 4,184 6,532 9,909 0.0 0.0   Gross profit growth   6.5% 39.5% -37.4% 127.6% 56.1% 51.7% -100.0% 0.0%   Employees   0 0 4 4 6 7 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 50.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   636 1,098 1,055 3,875 6,392 7,522 71 71   Balance sheet change%   13.8% 72.6% -3.9% 267.2% 65.0% 17.7% -99.1% 0.0%   Added value   241.6 468.4 -162.0 -708.1 -1,017.1 802.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -135 -128 447 1,205 1,258 -908 -3,325 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 -2.0 -3.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.3% 13.8% -12.0% -20.1% -17.6% 2.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   29.2% 46.6% -20.5% -32.7% -19.2% 4.2% 0.0% 0.0%   ROI %   54.8% 77.3% -43.0% -46.0% -22.4% 5.1% 0.0% 0.0%   ROE %   66.0% 51.0% -36.6% -27.6% -20.2% -7.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   64.0% 49.2% 35.3% -5.2% -16.3% -19.1% -96.4% -96.4%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -109.3% -85.6% 46.7% -433.3% -1,154.1% 807.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% -1,536.0% -543.7% -405.8% -103.7% -103.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 1.0% 4.0% 5.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.9 1.2 0.2 0.6 0.9 1.4 0.0 0.0   Current Ratio   2.2 2.1 0.6 1.3 2.0 2.8 0.0 0.0   Cash and cash equivalent   264.1 401.0 75.7 197.0 183.7 746.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   254.9 534.1 -285.3 328.2 1,053.5 2,322.5 -988.2 -988.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -40 -177 -170 115 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -40 -177 -95 115 0 0   EBIT / employee   0 0 -55 -210 -192 39 0 0   Net earnings / employee   0 0 -42 -146 -172 -76 0 0